Xuechi Lin

433 total citations
11 papers, 381 citations indexed

About

Xuechi Lin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Xuechi Lin has authored 11 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Xuechi Lin's work include Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers) and RNA modifications and cancer (3 papers). Xuechi Lin is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers) and RNA modifications and cancer (3 papers). Xuechi Lin collaborates with scholars based in China, Canada and Ethiopia. Xuechi Lin's co-authors include Dan Long, Ying Liao, Fang Shen, Xian Chen, Ting Yu, Fang Shen, Ting Yu, Xian Chen, Ting Yu and Xiaoqian Ma and has published in prestigious journals such as International Journal of Cancer, Cancer Science and Journal of Parasitology.

In The Last Decade

Xuechi Lin

11 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuechi Lin China 10 216 113 75 66 55 11 381
Sonal M. Manohar India 13 237 1.1× 157 1.4× 74 1.0× 81 1.2× 48 0.9× 29 490
Subhash C. Chauhan United States 11 266 1.2× 98 0.9× 78 1.0× 50 0.8× 32 0.6× 31 499
Perry Dhaliwal India 2 251 1.2× 99 0.9× 66 0.9× 39 0.6× 30 0.5× 3 393
Soo‐Yeon Hwang South Korea 10 220 1.0× 115 1.0× 66 0.9× 65 1.0× 23 0.4× 22 374
Jingya Sun China 11 234 1.1× 92 0.8× 73 1.0× 43 0.7× 42 0.8× 17 400
Chutima Talabnin Thailand 11 193 0.9× 75 0.7× 74 1.0× 33 0.5× 25 0.5× 31 382
Yongping Cui China 5 228 1.1× 99 0.9× 56 0.7× 41 0.6× 24 0.4× 10 437
Hossain Ahmed Bangladesh 3 210 1.0× 136 1.2× 85 1.1× 37 0.6× 16 0.3× 6 450
Chee Onn Leong Malaysia 5 236 1.1× 105 0.9× 90 1.2× 46 0.7× 23 0.4× 8 416
Seung Yeob Hyun South Korea 13 264 1.2× 80 0.7× 82 1.1× 31 0.5× 34 0.6× 14 371

Countries citing papers authored by Xuechi Lin

Since Specialization
Citations

This map shows the geographic impact of Xuechi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuechi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuechi Lin more than expected).

Fields of papers citing papers by Xuechi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuechi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuechi Lin. The network helps show where Xuechi Lin may publish in the future.

Co-authorship network of co-authors of Xuechi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xuechi Lin. A scholar is included among the top collaborators of Xuechi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuechi Lin. Xuechi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Zhao, Yan, Fang Shen, Dan Long, et al.. (2018). In�vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells. Oncology Reports. 41(1). 501–511. 31 indexed citations
3.
Long, Dan, Ting Yu, Xian Chen, Ying Liao, & Xuechi Lin. (2017). RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo. Cell Biology and Toxicology. 34(1). 7–21. 14 indexed citations
4.
Chen, Xian, Ying Liao, Dan Long, et al.. (2017). The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro. International Journal of Molecular Medicine. 40(1). 235–242. 83 indexed citations
5.
Shen, Fang, Dan Long, Ting Yu, et al.. (2017). Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin. Oncology Reports. 37(4). 2481–2489. 33 indexed citations
6.
Lin, Xuechi, Ying Liao, Xian Chen, et al.. (2016). Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 31(2). 37–43. 73 indexed citations
7.
Lin, Xuechi, Ting Yu, Lingxi Zhang, et al.. (2016). Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High‐Grade Differentiation of Xenografted Tumours in Nude Mice. Basic & Clinical Pharmacology & Toxicology. 119(6). 611–620. 38 indexed citations
8.
Lin, Xuechi, et al.. (2014). Op18/Stathmin Is Involved in the Resistance of Taxol Among Different Epithelial Carcinoma Cell Lines. Cancer Biotherapy and Radiopharmaceuticals. 29(9). 376–386. 17 indexed citations
9.
Lin, Xuechi, Min Tang, Yongguang Tao, et al.. (2012). Epstein–Barr virus‐encoded LMP1 triggers regulation of the ERK‐mediated Op18/stathmin signaling pathway in association with cell cycle. Cancer Science. 103(6). 993–999. 27 indexed citations
10.
Zeng, Tiebing, et al.. (2008). Schistosoma japonicum: Protective Immunity Induced by Schistosomulum-Derived Cells in a Mouse Model. Journal of Parasitology. 94(2). 395–403. 2 indexed citations
11.
Lin, Xuechi, Sufang Liu, Xiangjian Luo, et al.. (2008). EBV‐encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells. International Journal of Cancer. 124(5). 1020–1027. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026